The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1111/cas.13738
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneity of tumor lymphangiogenesis: Progress and prospects

Abstract: Lymphangiogenesis and increased expression of lymphangiogenic growth factors are associated with high rates of lymph node (LN) metastasis and with poor prognosis in some, but not all, solid tumors. In addition to its involvement in metastasis, lymphangiogenesis has been shown to have other roles in tumor pathogenesis, such as the niche function of tumor stem cells and regulatory functions of antitumor immune responses. In contrast, evidence has accumulated that tumor‐induced lymphangiogenesis displays the hete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 75 publications
(146 reference statements)
0
14
0
Order By: Relevance
“…There is no data regarding the interaction of CLR with key factors that are thought to promote lymphatic metastasis, including members of the vascular endothelial growth factor (VEGF) secreted glycoproteins, as well as insulin and hepatocyte growth factors (7779). Several cytokines, including CCL21 through the activation of CCR7 (80, 81), CCL5 and CXCL10 (82), have been implicated in metastatic lymphangiogenesis as well as the formation and maintenance of CLR and other tumor-specific immune responses.…”
Section: Introductionmentioning
confidence: 99%
“…There is no data regarding the interaction of CLR with key factors that are thought to promote lymphatic metastasis, including members of the vascular endothelial growth factor (VEGF) secreted glycoproteins, as well as insulin and hepatocyte growth factors (7779). Several cytokines, including CCL21 through the activation of CCR7 (80, 81), CCL5 and CXCL10 (82), have been implicated in metastatic lymphangiogenesis as well as the formation and maintenance of CLR and other tumor-specific immune responses.…”
Section: Introductionmentioning
confidence: 99%
“…The remodelling of regional LVs to facilitate tumour cell dissemination plays an important pro-metastatic role in solid tumours, especially in cervical squamous cell carcinoma (CSCC) [6]. However, recent studies suggest that LVs are heterogeneous in their differential response to various micro-environmental signals and thus display distinct phenotypes and functions, which hinder their application in diagnosis and targeted therapy [7]. Different LV populations that secrete distinct profiles of cytokines have been identified in a variety of cancers [8].…”
Section: Introductionmentioning
confidence: 99%
“…It has been well established that lymphangiogenesis can occur in and around tumors ( 23 ). However, the functional significance of intratumoral and peritumoral lymphatics involved in the pathology of tumors remains controversial.…”
Section: Discussionmentioning
confidence: 99%